Recent News: Vermillion Announces Acceptance of Publication: Ethnic Disparity Data Showing OVA1 (MIA) Superiority over CA125 and HE4 in Detecting Ovarian Cancer Risk

Our Products

How We’re Transforming Ovarian Cancer Detection

We concentrate our development of novel diagnostic tests for gynecologic disease, with an initial focus on ovarian cancer.